These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37481872)

  • 1. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs.
    Magura S; Lee-Easton MJ; Abu-Obaid R; Reed P; Allgaier B; Amaratunga P; Lorenz-Lemberg B; Levitas M; Achtyes ED
    Drug Alcohol Depend; 2023 Sep; 250():110894. PubMed ID: 37481872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
    West R; Mikel C; Hofilena D; Guevara M
    Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
    Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
    J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
    Truver MT; Palmquist KB; Swortwood MJ
    J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum methadone compliance testing: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(21):1-54. PubMed ID: 23074492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
    Dale RC; Ford LT; Street C
    Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States.
    Lee-Easton MJ; Magura S; Abu-Obaid R; Reed P; Allgaier B; Fish E; Maletta A; Amaratunga P; Lorenz-Lemberg B; Levitas M; Achtyes E
    J Psychoactive Drugs; 2024 Feb; ():1-12. PubMed ID: 38329134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
    Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS
    J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
    Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
    Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling Procedures.
    Zheng Y; Sparve E; Sparring S; Bergström M
    J Anal Toxicol; 2021 Jan; 44(9):1004-1011. PubMed ID: 32128555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
    Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
    Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
    Carlsson S; Olsson R; Lindkvist I; Beck O
    Scand J Clin Lab Invest; 2015 Apr; 75(2):156-61. PubMed ID: 25562730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Cavity Fluid as an Investigative Approach for Qualitative and Quantitative Evaluations of Drugs in Postmortem Subjects.
    Reisinger AJ; Miller AC; Shaw LA; Champion JL; Neiswonger MA
    J Anal Toxicol; 2019 Jul; 43(6):444-451. PubMed ID: 31062851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance by oral fluid of drugs subject to misuse among individuals under arrest.
    Magura S; Weller BE; Smith DR; Saxton MM; Amaratunga P
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):247-254. PubMed ID: 33481634
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of Drugs in Oral Fluid Using LC-MS/MS.
    Coulter CA; Moore CM
    Methods Mol Biol; 2019; 1872():237-259. PubMed ID: 30350295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).
    Smink BE; Mathijssen MP; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
    J Anal Toxicol; 2006 Sep; 30(7):478-85. PubMed ID: 16959142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.
    Liu HC; Lee HT; Hsu YC; Huang MH; Liu RH; Chen TJ; Lin DL
    J Anal Toxicol; 2015; 39(6):472-80. PubMed ID: 25935159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.